CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
Zurich, Zurich - April 10, 2026 - PRESSADVANTAGE - IntroDrink, the Swiss premium natural health retailer, has expanded ...
EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...
During pregnancy, the maternal immune system must engage in a fine balancing act: maintaining tolerance to the fetal ...
Every bit of zinc counts, especially for people eating a mostly plant-based diet, dietitians say. These fruits contain the ...
Scientists have uncovered an important new link between the brain and immune system after stroke, which could lead to ...
Chief Financial Officer Robin Kramer explained how the deal not only provides two marketed products, but a team with ...
Acquisition will bring two differentiated commercialized immunology medicines to Biogen with EMPAVELI® FDA-approved in three indications, ...
The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...
Although many things can affect your individual prognosis, about half of all patients will reach kidney failure within 10 years of their diagnosis and need dialysis or a kidney transplant. Even after ...
Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio Follows breakthrough non-human primate data demonstrating deep B-cell depletion without cytokine release Commit is poised to nominate its ...
The MarketWatch News Department was not involved in the creation of this content. -- Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher Bio -- Follows breakthrough non-human primate data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results